In a welcome move, Tempus AI saw its Relative Strength Rating rise from 62 to 71 on Friday.
This unique rating identifies technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the best stocks tend to have an 80 or higher RS Rating as they begin their biggest price moves. See if Tempus AI can continue to show renewed price strength and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Tempus AI is not currently offering a proper buying opportunity. See if the stock goes on to form a base that could ignite a new run.
The company posted 0% earnings growth last quarter, while sales growth came in at 25%. Keep an eye out for the company's next round of numbers on or around Nov. 7.
Tempus AI holds the No. 26 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte, Natera and Catalent are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
